Esai and Biogen, Lequembi manufacturer, receive FDA approval for Alzheimer's drug. Eisai and Biogen's drug, sold under the brand name Leqembi, is the first amyloid-targeting medication to pass the FDA's full review. Source 8o.
Sponsored Links:
Post Date:Wed Jun 18 6:06:13 GMT 2025 / Post ID: #
Comment
Lecanemab
More opinions appreciated on lecanemab this needs looking into now so as to find lecanemab understanding become more aware about lecanemab.
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,